INTS vs PTC
Intensity Therapeutics, Inc. Common stock (INTS) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
PTC Inc (PTC) is a software - application company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. Revenue was up 19.2% from 2024-09-30 to 2025-09-30. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
INTS currently screens at market cap $7.7M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the INTS and PTC stock pages for the full models.
Not investment advice.